Simplified monomeric VHH-Fc antibodies provide new opportunities for passive immunization.
Journal
Current opinion in biotechnology
ISSN: 1879-0429
Titre abrégé: Curr Opin Biotechnol
Pays: England
ID NLM: 9100492
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
03
09
2019
revised:
31
10
2019
accepted:
04
11
2019
pubmed:
7
12
2019
medline:
28
8
2020
entrez:
7
12
2019
Statut:
ppublish
Résumé
Simplified monomeric monoclonal antibodies consisting of a single-domain VHH, derived from camelid heavy-chain only antibodies, fused with the Fc domain of either IgG (VHH-IgG) or IgA (VHH-IgA) antibodies, are promising therapeutic proteins. These simplified single-gene encoded antibodies are much easier to manufacture and can be produced in plants and in yeast for bulk applications. These merits enable novel passive immunization applications, such as in-feed oral delivery of VHH-IgAs, which have successfully provided protection against a gastrointestinal infection in the piglet model.
Identifiants
pubmed: 31810049
pii: S0958-1669(19)30116-8
doi: 10.1016/j.copbio.2019.11.006
pii:
doi:
Substances chimiques
Antibodies, Monoclonal
0
Immunoglobulin Fc Fragments
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
96-101Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.